BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
1 | 437.00 | 439.80 | 100 |
9 | 436.00 | 440.45 | 150 |
36 | 435.00 | 448.00 | 198 |
150 | 434.50 | 450.00 | 76 |
1 | 434.00 | 450.55 | 46 |
8983 | Total | Total | 6071 |
As on 31 Mar, 2023 | 04:01
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
1 | 437.00 | 439.80 | 100 |
9 | 436.00 | 440.45 | 150 |
36 | 435.00 | 448.00 | 198 |
150 | 434.50 | 450.00 | 76 |
1 | 434.00 | 450.55 | 46 |
8983 | Total | Total | 6071 |
Stock with good financial performance alongside good to expensive valuation
Open | 450.20 |
Previous Close | 451.70 |
Volume | 1,529,683.00 |
Value (Lacs) | 6,747.43 |
VWAP | 444.56 |
Beta |
High | 451.35 |
Low | 436.00 |
UC Limit | 542.00 |
LC Limit | 361.40 |
52 Week High | 482.80 |
52 Week Low | 338.20 |
TTM EPS See historical trend | 10.06 (+77.05% YoY) |
TTM PE See historical trend | 43.85 (Average PE) |
P/B See historical trend | 6.82 (High P/B) |
Face Value | 10.00 |
Mkt Cap (Rs. Cr.) | 42,827 |
Dividend Yield | 0.00 |
20D Avg Volume | 2,207,889 |
20D Avg Delivery(%) | 71.39 |
Sector PE | 64.96 |
Book Value Per Share | 64.72 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
NSE to make replacement of stocks in 42 indices, removes Paytm from Nifty Next 50 Feb 18 2023 07:02 AM
Buy Max Healthcare Institute; target of Rs 500: Prabhudas Lilladher Feb 08 2023 06:02 PM
Max Healthcare Consolidated December 2022 Net Sales at Rs 1,141.24 crore, up 17.15% Y-o-Y Feb 02 2023 11:02 PM
Max Healthcare Standalone December 2022 Net Sales at Rs 481.97 crore, up 21.18% Y-o-Y Feb 02 2023 11:02 PM
Qty 699791 | Price 445.1 | % Traded 0.07 |
Qty 699791 | Price 445.1 | % Traded 0.07 |
Qty 699791 | Price 464.45 | % Traded 0.07 |
Qty 699791 | Price 464.45 | % Traded 0.07 |
Qty 376488 | Price 411.55 | % Traded 0.04 |
Qty 267293 | Price 411.55 | % Traded 0.03 |
Qty 376488 | Price 411.55 | % Traded 0.04 |
Qty 267293 | Price 411.55 | % Traded 0.03 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 51948594 | Price 353 | % Traded 5.35 |
Qty 43751218 | Price 353 | % Traded 4.51 |
Qty 26549556 | Price 353 | % Traded 2.73 |
Qty 21630000 | Price 353 | % Traded 2.23 |
Qty 10605621 | Price 353 | % Traded 1.09 |
Qty 10546540 | Price 353 | % Traded 1.09 |
Qty 8041075 | Price 353 | % Traded 0.83 |
Qty 8041075 | Price 353 | % Traded 0.83 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Qty 6874447 | Price 0 | % Traded 0.71 | Post Tnx Hold. 0% |
Qty 6874447 | Price 0 | % Traded 0.71 | Post Tnx Hold. 23.8% |
Qty 260196762 | Price 353.03 | % Traded 26.83 | Post Tnx Hold. 0.71% |
Qty 95143 | Price 342.55 | % Traded 0.01 | Post Tnx Hold. 0.01% |
Qty 17000 | Price 399.95 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 13000 | Price 405 | % Traded 0.00 | Post Tnx Hold. 0.01% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
Qty 3895200 | Price 0 | % Traded 0.40 | Post Tnx Hold. 5.18% |
Qty 62495134 | Price 0 | % Traded 6.45 | Post Tnx Hold. 7.85% |
Qty 65381218 | Price 0 | % Traded 6.74 | Post Tnx Hold. 6.74% |
Qty 0 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 30863440 | Price 0 | % Traded 3.18 | Post Tnx Hold. 6.92% |
Qty 260196762 | Price 0 | % Traded 26.83 | Post Tnx Hold. 0.7% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Max Healthcare | 441.10 | -2.35 | 42,827.41 | 43.85 | 6.81 | 9.63 | 26.88 | 605 | 3,931 | 0.12 |
Apollo Hospital | 4,310.90 | -1.19 | 61,984.13 | 81.06 | 10.51 | 18.77 | -4.54 | 1,101 | 14,662 | 0.47 |
Fortis Health | 259.90 | -0.86 | 19,621.36 | 37.45 | 2.80 | 8.98 | -10.50 | 765 | 5,717 | 0.16 |
Narayana Hruda | 774.15 | 0.72 | 15,820.59 | 31.51 | 10.62 | 22.96 | 3.86 | 350 | 3,701 | 0.37 |
Dr Lal PathLab | 1,828.10 | 1.56 | 15,240.48 | 62.58 | 9.87 | 22.86 | -29.98 | 350 | 2,087 | 0.23 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>